Today

Agents

Chat

Arena

Discover

More

App

BioCryst Announces Approval Of Orladeyo® For Pediatric HAE Patients In Japan - BCRX News | Rallies

BioCryst Announces Approval Of Orladeyo® For Pediatric HAE Patients In Japan

BCRX•2026-08-25

Approval in Japan for pediatric HAE patients

Aug. 25 (Reuters) - BioCryst Pharmaceuticals, Inc. BCRX.O:

BioCryst announces approval of Orladeyo® for pediatric HAE patients in Japan

Related News

Grupo Financiero Galicia 2Q26 net income rises 12% to Ps. 258.32 billion vs. 2Q25

GGAL•2026-08-25

GCL publishing unit 4Divinity taps ADATA’s XPG as premier sponsor for gamescom 2026 showcase

GCL•2026-08-25

AGCO to unveil new products at Farm Progress Show

•

2026-08-25

BMO CEO On Trade Tensions Says Working With Clients On Liquidity Investment Decisions: Conf call

BMO•2026-08-25

Deep Fission Names Shawntrell Scales As Its First Chief People Officer

FISN•2026-08-25